Related Experiment Video

Updated: Jun 25, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis

B Cariou1

  • 1Université de Nantes, Faculté de Médecine, 44093 Nantes cedex, France. betrand.cariou@univ-nantes.fr

Diabetes & Metabolism
|February 7, 2009
PubMed

Insights

Farnesoid X receptor (FXR) activation shows promise for treating non-alcoholic steatohepatitis (NASH) by improving lipid and glucose metabolism. Further clinical studies are needed to confirm its therapeutic potential in humans.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hepatology

Background:

  • The farnesoid X receptor (FXR) is a nuclear receptor crucial for regulating bile acid, lipid, and glucose homeostasis.
  • FXR is primarily expressed in the liver, intestine, kidney, and adipose tissue, playing a key role in metabolic control.

Purpose of the Study:

  • To explore the therapeutic potential of FXR agonists and/or modulators (SBARMs) for treating non-alcoholic steatohepatitis (NASH).
  • To highlight FXR's role in metabolic regulation and liver health.

Main Methods:

  • Review of existing preclinical and clinical data on FXR activation and its effects.
  • Analysis of FXR's impact on hepatic de novo lipogenesis, insulin sensitivity, and hepatocyte protection.

Main Results:

  • FXR activation demonstrates potential in preclinical models by inhibiting hepatic lipogenesis and enhancing insulin sensitivity.
  • FXR activation protects hepatocytes from bile acid-induced damage and plays a role in liver regeneration and hepatocarcinogenesis.

Conclusions:

  • FXR is a promising therapeutic target for NASH, with potential benefits including improved metabolic profiles and liver protection.
  • While preclinical data are supportive, robust clinical trials in humans are essential to validate FXR-based therapies for NASH.

More Related Videos

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells09:15

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells

Published on: July 18, 2019

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...